REG - Bridgepoint Advisers Spire Healthcare Grp - Statement regarding Spire Healthcare Group

Spire HealthcareAnnouncement

20/03/2026 17:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260320:nRST5535Xa&default-theme=true

RNS Number : 5535X  Bridgepoint Advisers Limited  20 March 2026

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE
OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A
VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE UK CITY CODE ON
TAKEOVERS AND MERGERS (THE "CODE").

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

FOR IMMEDIATE RELEASE

 

20 March 2026

 

Statement regarding Spire Healthcare Group plc ("Spire Healthcare", the
"Company")

 

Further to the announcement by Spire Healthcare on 18 February, Bridgepoint
Advisers Limited ("Bridgepoint") confirms that it does not intend to make an
offer for Spire Healthcare.

Bridgepoint is grateful for the efforts of the Spire Healthcare Board over the
course of its participation in the Formal Sale Process, but Bridgepoint has
been unable to get sufficient confidence as to a transaction structure that
would work for all stakeholders at this time.

As a result of this announcement, Bridgepoint will, except with the consent of
the UK Panel on Takeovers and Mergers (the "Panel"), be bound by the
restrictions contained in Rule 2.8 of the Code.

For the purposes of Rule 2.8 of the Code, Bridgepoint reserve the right,
either together or individually, to announce or participate in an offer or
possible offer for Spire Healthcare and/or to take any other action which
would otherwise be restricted under Rule 2.8 of the Code within 6 months after
the date of this announcement in the following circumstances described in note
2 to Rule 2.8 of the Code: (i) with the consent of the Board of Spire
Healthcare; (ii) if a third party announces a firm intention to make an offer
for Spire Healthcare; (iii) if Spire Healthcare announces a Rule 9 waiver
proposal (see Note 1 of the Notes on Dispensations from Rule 9) or a reverse
takeover (as defined in the Code); or (iv) if the Panel determines there has
been a material change of circumstances.

 

Enquiries:

 

Bridgepoint

Christian
Jones
                                +44 (0) 20 7034
3500

Nicole Gregory

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRAKKBKOBKDCNB



            Copyright 2019 Regulatory News Service, all rights reserved